Patents Assigned to The Dept. of Veterans Affairs Office of The General Counsel
  • Compositions and methods for inhibiting squamous cell carcinoma
    Patent number: 7875277
    Abstract: The present invention relates to compositions and methods for detecting and inhibiting squamous cell carcinoma using agents that target the laminin 5 alpha 3 G4-G5 domain.
    Type: Grant
    Filed: April 14, 2008
    Date of Patent: January 25, 2011
    Assignees: The Dept. of Veterans Affairs Office of The General Counsel, The Board of Trustees of the Leland Stanford Junior University
    Inventor: M. Peter Marinkovich
  • Promoter variants of the alpha-7 nicotinic acetylcholine receptor
    Publication number: 20040185468
    Abstract: The present invention is directed to methods and compositions related to &agr;7 acetylcholine nicotinic receptor genes, in particular, the human &agr;7 nicotinic acetylcholine receptor gene. The human &agr;7 nicotinic acetylcholine receptor gene is associated with the pathophysiological aspects of the disease schizophrenia. The present invention further provides methods and compositions to screen populations for abnormal &agr;7 alleles, as well as methods and compositions for development of therapeutics.
    Type: Application
    Filed: November 26, 2003
    Publication date: September 23, 2004
    Applicant: The U. S. A. as represented by the Dept. of Veterans Affairs, Office of General Counsel
    Inventors: Sherry Leonard, Robert Freedman